{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:06:26Z","timestamp":1792134386143,"version":"4.4.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007569","name":"Carl Zeiss Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KoRS\u2010CB,GSC 2018"],"award-info":[{"award-number":["KoRS\u2010CB,GSC 2018"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004361","name":"Swiss Cancer League","doi-asserted-by":"publisher","award":["KFS\u20104384\u201002\u20102018"],"award-info":[{"award-number":["KFS\u20104384\u201002\u20102018"]}],"id":[{"id":"10.13039\/501100004361","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Rep"],"published-print":{"date-parts":[[2022,9,5]]},"DOI":"10.15252\/embr.202154195","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T04:31:28Z","timestamp":1657254688000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["LRH\u20101\/NR5A2 interacts with the glucocorticoid receptor to regulate glucocorticoid resistance"],"prefix":"10.1038","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5099-5814","authenticated-orcid":false,"given":"Svenja","family":"Michalek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Goj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Pia","family":"Plazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blerim","family":"Marovca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2890-3191","authenticated-orcid":false,"given":"Beat","family":"Bornhauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1594-4712","authenticated-orcid":false,"given":"Thomas","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"key":"BFEMBR202154195_CR1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1189\/jlb.71.1.9","volume":"71","author":"WY Almawi","year":"2002","unstructured":"Almawi WY, Melemedjian OK (2002) Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor. J Leukoc Biol 71: 9\u201315","journal-title":"J Leukoc Biol"},{"key":"BFEMBR202154195_CR2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1752-0509-1-34","volume":"1","author":"GD Amoutzias","year":"2007","unstructured":"Amoutzias GD, Pichler EE, Mian N, De Graaf D, Imsiridou A, Robinson\u2010Rechavi M, Bornberg\u2010Bauer E, Robertson DL, Oliver SG (2007) A protein interaction atlas for the nuclear receptors: properties and quality of a hub\u2010based dimerisation network. BMC Syst Biol 1: 34","journal-title":"BMC Syst Biol"},{"key":"BFEMBR202154195_CR3","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1158\/0008-5472.CAN-06-4244","volume":"67","author":"PS Bachmann","year":"2007","unstructured":"Bachmann PS, Gorman R, Papa RA, Bardell JE, Ford J, Kees UR, Marshall GM, Lock RB (2007) Divergent mechanisms of glucocorticoid resistance in experimental models of pediatric acute lymphoblastic leukemia. Cancer Res 67: 4482\u20134490","journal-title":"Cancer Res"},{"key":"BFEMBR202154195_CR4","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1038\/s41467-018-06137-w","volume":"9","author":"JR Bayrer","year":"2018","unstructured":"Bayrer JR, Wang H, Nattiv R, Suzawa M, Escusa HS, Fletterick RJ, Klein OD, Moore DD, Ingraham HA (2018) LRH\u20101 mitigates intestinal inflammatory disease by maintaining epithelial homeostasis and cell survival. Nat Commun 9: 4055","journal-title":"Nat Commun"},{"key":"BFEMBR202154195_CR5","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1210\/endo.133.2.8344212","volume":"133","author":"CA Beck","year":"1993","unstructured":"Beck CA, Estes PA, Bona BJ, Muro\u2010Cacho CA, Nordeen SK, Edwards DP (1993) The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors. Endocrinology 133: 728\u2013740","journal-title":"Endocrinology"},{"key":"BFEMBR202154195_CR6","doi-asserted-by":"crossref","first-page":"19830","DOI":"10.1074\/jbc.M112.411686","volume":"288","author":"C Benod","year":"2013","unstructured":"Benod C, Carlsson J, Uthayaruban R, Hwang P, Irwin JJ, Doak AK, Shoichet BK, Sablin EP, Fletterick RJ (2013) Structure\u2010based discovery of antagonists of nuclear receptor LRH\u20101. J Biol Chem 288: 19830\u201319844","journal-title":"J Biol Chem"},{"key":"BFEMBR202154195_CR7","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cell.2006.06.049","volume":"126","author":"AL Bookout","year":"2006","unstructured":"Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, Mangelsdorf DJ (2006) Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126: 789\u2013799","journal-title":"Cell"},{"key":"BFEMBR202154195_CR8","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1182\/blood-2006-12-060970","volume":"110","author":"BC Bornhauser","year":"2007","unstructured":"Bornhauser BC, Bonapace L, Lindholm D, Martinez R, Cario G, Schrappe M, Niggli FK, Sch\u00e4fer BW, Bourquin J\u2010P (2007) Low\u2010dose arsenic trioxide sensitizes glucocorticoid\u2010resistant acute lymphoblastic leukemia cells to dexamethasone via an Akt\u2010dependent pathway. Blood 110: 2084\u20132091","journal-title":"Blood"},{"key":"BFEMBR202154195_CR9","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1210\/er.2002-0006","volume":"24","author":"K de Bosscher","year":"2003","unstructured":"de Bosscher K, vanden Berghe W, Haegeman G (2003) The interplay between the glucocorticoid receptor and nuclear factor\u2010\u03baB or activator protein\u20101: molecular mechanisms for gene repression. Endocr Rev 24: 488\u2013522","journal-title":"Endocr Rev"},{"key":"BFEMBR202154195_CR10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.molcel.2004.07.009","volume":"15","author":"OA Botrugno","year":"2004","unstructured":"Botrugno OA, Fayard E, Annicotte JS, Haby C, Brennan T, Wendling O, Tanaka T, Kodama T, Thomas W, Auwerx J et\u2009al (2004) Synergy between LRH\u20101 and beta\u2010catenin induces G1 cyclin\u2010mediated cell proliferation. Mol Cell 15: 499\u2013509","journal-title":"Mol Cell"},{"key":"BFEMBR202154195_CR11","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.ccell.2018.11.011","volume":"34","author":"JA Brown","year":"2018","unstructured":"Brown JA, Ferrando A (2018) Glucocorticoid resistance in acute lymphoblastic leukemia: BIM finally. Cancer Cell 34: 869\u2013871","journal-title":"Cancer Cell"},{"key":"BFEMBR202154195_CR12","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.yexcr.2007.11.003","volume":"314","author":"G Brumatti","year":"2008","unstructured":"Brumatti G, Yon M, Castro FA, Bueno\u2010da\u2010Silva AEB, Jacysyn JF, Brunner T, Amarante\u2010Mendes GP (2008) Conversion of CD95 (Fas) Type II into Type I signaling by sub\u2010lethal doses of cycloheximide. Exp Cell Res 314: 554\u2013563","journal-title":"Exp Cell Res"},{"key":"BFEMBR202154195_CR13","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41580-020-00322-w","volume":"22","author":"B Canovas","year":"2021","unstructured":"Canovas B, Nebreda AR (2021) Diversity and versatility of p38 kinase signalling in health and disease. Nat Rev Mol Cell Biol 22: 346\u2013366","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFEMBR202154195_CR14","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.2147\/OTT.S157759","volume":"11","author":"Q Chen","year":"2018","unstructured":"Chen Q, Yuan H, Shi GD, Wu Y, Liu DF, Lin YT, Chen L, Ge WL, Jiang K, Miao Y (2018) Association between NR5A2 and the risk of pancreatic cancer, especially among Caucasians: a meta\u2010analysis of case\u2010control studies. Onco Targets Ther 11: 2709\u20132723","journal-title":"Onco Targets Ther"},{"key":"BFEMBR202154195_CR15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188430","volume":"1874","author":"D Clarisse","year":"2020","unstructured":"Clarisse D, Offner F, De Bosscher K (2020) Latest perspectives on glucocorticoid\u2010induced apoptosis and resistance in lymphoid malignancies. Biochim Biophys Acta Rev Cancer 1874: 188430","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"BFEMBR202154195_CR16","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1124\/mol.114.095554","volume":"87","author":"CA Corzo","year":"2015","unstructured":"Corzo CA, Mari Y, Chang MR, Khan T, Kuruvilla D, Nuhant P, Kumar N, West GM, Duckett DR, Roush WR et\u2009al (2015) Antiproliferation activity of a small molecule repressor of liver receptor homolog 1. Mol Pharmacol 87: 296\u2013304","journal-title":"Mol Pharmacol"},{"key":"BFEMBR202154195_CR17","volume":"2016","author":"LC Crowley","year":"2016","unstructured":"Crowley LC, Marfell BJ, Scott AP, Waterhouse NJ (2016) Quantitation of apoptosis and necrosis by annexin v binding, propidium iodide uptake, and flow cytometry. Cold Spring Harb Protoc 2016: pdb.prot087288","journal-title":"Cold Spring Harb Protoc"},{"key":"BFEMBR202154195_CR18","doi-asserted-by":"crossref","first-page":"5.25.21","DOI":"10.1002\/0471142301.ns0525s35","volume":"35","author":"EA Elion","year":"2006","unstructured":"Elion EA (2006) Detection of protein\u2010protein interactions by coprecipitation. Curr Protoc Neurosci 35: 5.25.21\u201325.25.10","journal-title":"Curr Protoc Neurosci"},{"key":"BFEMBR202154195_CR19","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.3389\/fimmu.2019.01859","volume":"10","author":"L Escoter\u2010Torres","year":"2019","unstructured":"Escoter\u2010Torres L, Caratti G, Mechtidou A, Tuckermann J, Uhlenhaut NH, Vettorazzi S (2019) Fighting the fire: mechanisms of inflammatory gene regulation by the glucocorticoid receptor. Front Immunol 10: 1859","journal-title":"Front Immunol"},{"key":"BFEMBR202154195_CR20","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1182\/blood-2016-09-738070","volume":"129","author":"V Frismantas","year":"2017","unstructured":"Frismantas V, Dobay MP, Rinaldi A, Tchinda J, Dunn SH, Kunz J, Richter\u2010Pechanska P, Marovca B, Pail O, Jenni S et\u2009al (2017) Ex vivo drug response profiling detects recurrent sensitivity patterns in drug\u2010resistant acute lymphoblastic leukemia. Blood 129: e26\u2013e37","journal-title":"Blood"},{"key":"BFEMBR202154195_CR21","first-page":"371","volume":"26","author":"X Guo","year":"2013","unstructured":"Guo X, Zhou CY, Li Q, Gao J, Zhu YP, Gu L, Ma ZG (2013) Rapamycin sensitizes glucocorticoid resistant acute lymphoblastic leukemia CEM\u2010C1 cells to dexamethasone induced apoptosis through both mTOR suppression and up\u2010regulation and activation of glucocorticoid receptor. Biomed Environ Sci 26: 371\u2013381","journal-title":"Biomed Environ Sci"},{"key":"BFEMBR202154195_CR22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.immuni.2015.12.010","volume":"44","author":"MA Hauser","year":"2016","unstructured":"Hauser MA, Schaeuble K, Kindinger I, Impellizzieri D, Krueger WA, Hauck CR, Boyman O, Legler DF (2016) Inflammation\u2010induced CCR7 oligomers form scaffolds to integrate distinct signaling pathways for efficient cell migration. Immunity 44: 59\u201372","journal-title":"Immunity"},{"key":"BFEMBR202154195_CR23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11899-018-0455-9","volume":"13","author":"M Hefazi","year":"2018","unstructured":"Hefazi M, Litzow MR (2018) Recent advances in the biology and treatment of T cell acute lymphoblastic leukemia. Curr Hematol Malig Rep 13: 265\u2013274","journal-title":"Curr Hematol Malig Rep"},{"key":"BFEMBR202154195_CR24","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.89","volume":"3","author":"N Heidari","year":"2012","unstructured":"Heidari N, Miller AV, Hicks MA, Marking CB, Harada H (2012) Glucocorticoid\u2010mediated BIM induction and apoptosis are regulated by Runx2 and c\u2010Jun in leukemia cells. Cell Death Dis 3: e349","journal-title":"Cell Death Dis"},{"key":"BFEMBR202154195_CR25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.stem.2009.12.009","volume":"6","author":"JC Heng","year":"2010","unstructured":"Heng JC, Feng B, Han J, Jiang J, Kraus P, Ng JH, Orlov YL, Huss M, Yang L, Lufkin T et\u2009al (2010) The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. Cell Stem Cell 6: 167\u2013174","journal-title":"Cell Stem Cell"},{"key":"BFEMBR202154195_CR26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00018-005-5390-y","volume":"63","author":"MJ Herold","year":"2006","unstructured":"Herold MJ, McPherson KG, Reichardt HM (2006) Glucocorticoids in T cell apoptosis and function. Cell Mol Life Sci 63: 60\u201372","journal-title":"Cell Mol Life Sci"},{"key":"BFEMBR202154195_CR27","volume-title":"StatPearls","author":"A Hodgens","year":"2022","unstructured":"Hodgens A, Sharman T (2022) Corticosteroids. In StatPearls. Treasure Island, FL: StatPearls Publishing"},{"key":"BFEMBR202154195_CR28","doi-asserted-by":"crossref","first-page":"ra20","DOI":"10.1126\/scisignal.2004786","volume":"7","author":"SC Huang","year":"2014","unstructured":"Huang SC, Lee CT, Chung BC (2014) Tumor necrosis factor suppresses NR5A2 activity and intestinal glucocorticoid synthesis to sustain chronic colitis. Sci Signal 7: ra20","journal-title":"Sci Signal"},{"key":"BFEMBR202154195_CR29","doi-asserted-by":"crossref","first-page":"12483","DOI":"10.1093\/nar\/gkaa1002","volume":"48","author":"S Hume","year":"2020","unstructured":"Hume S, Dianov GL, Ramadan K (2020) A unified model for the G1\/S cell cycle transition. Nucleic Acids Res 48: 12483\u201312501","journal-title":"Nucleic Acids Res"},{"key":"BFEMBR202154195_CR30","doi-asserted-by":"crossref","first-page":"W488","DOI":"10.1093\/nar\/gkaa216","volume":"48","author":"A Ianevski","year":"2020","unstructured":"Ianevski A, Giri AK, Aittokallio T (2020) SynergyFinder 2.0: visual analytics of multi\u2010drug combination synergies. Nucleic Acids Res 48: W488\u2013W493","journal-title":"Nucleic Acids Res"},{"key":"BFEMBR202154195_CR31","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1093\/bioinformatics\/btx162","volume":"33","author":"A Ianevski","year":"2017","unstructured":"Ianevski A, He L, Aittokallio T, Tang J (2017) SynergyFinder: a web application for analyzing drug combination dose\u2010response matrix data. Bioinformatics 33: 2413\u20132415","journal-title":"Bioinformatics"},{"key":"BFEMBR202154195_CR32","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S1470-2045(10)70114-5","volume":"11","author":"H Inaba","year":"2010","unstructured":"Inaba H, Pui CH (2010) Glucocorticoid use in acute lymphoblastic leukaemia. Lancet Oncol 11: 1096\u20131106","journal-title":"Lancet Oncol"},{"key":"BFEMBR202154195_CR33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1182\/blood-2014-05-576470","volume":"125","author":"D Jing","year":"2015","unstructured":"Jing D, Bhadri VA, Beck D, Thoms JA, Yakob NA, Wong JW, Knezevic K, Pimanda JE, Lock RB (2015) Opposing regulation of BIM and BCL2 controls glucocorticoid\u2010induced apoptosis of pediatric acute lymphoblastic leukemia cells. Blood 125: 273\u2013283","journal-title":"Blood"},{"key":"BFEMBR202154195_CR34","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev.biophys.37.032807.125842","volume":"37","author":"TK Kerppola","year":"2008","unstructured":"Kerppola TK (2008) Bimolecular fluorescence complementation (BiFC) analysis as a probe of protein interactions in living cells. Annu Rev Biophys 37: 465\u2013487","journal-title":"Annu Rev Biophys"},{"key":"BFEMBR202154195_CR35","first-page":"9.1.1","volume":"63","author":"RE Kingston","year":"2003","unstructured":"Kingston RE, Chen CA, Rose JK (2003) Calcium phosphate transfection. Curr Protoc Mol Biol 63: 9.1.1\u20139.1.11","journal-title":"Curr Protoc Mol Biol"},{"key":"BFEMBR202154195_CR36","doi-asserted-by":"crossref","DOI":"10.1621\/nrs.06005","volume":"6","author":"M Kininis","year":"2008","unstructured":"Kininis M, Kraus WL (2008) A global view of transcriptional regulation by nuclear receptors: gene expression, factor localization, and DNA sequence analysis. Nucl Recept Signal 6: e005","journal-title":"Nucl Recept Signal"},{"key":"BFEMBR202154195_CR37","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1210\/me.2007-0565","volume":"22","author":"Y\u2010K Lee","year":"2008","unstructured":"Lee Y\u2010K, Schmidt DR, Cummins CL, Choi M, Peng L, Zhang Y, Goodwin B, Hammer RE, Mangelsdorf DJ, Kliewer SA (2008) liver receptor homolog\u20101 regulates bile acid homeostasis but is not essential for feedback regulation of bile acid synthesis. Mol Endocrinol 22: 1345\u20131356","journal-title":"Mol Endocrinol"},{"key":"BFEMBR202154195_CR38","doi-asserted-by":"crossref","first-page":"6801","DOI":"10.1038\/ncomms7801","volume":"6","author":"L Lefevre","year":"2015","unstructured":"Lefevre L, Authier H, Stein S, Majorel C, Couderc B, Dardenne C, Eddine MA, Meunier E, Bernad J, Valentin A et\u2009al (2015) LRH\u20101 mediates anti\u2010inflammatory and antifungal phenotype of IL\u201013\u2010activated macrophages through the PPARgamma ligand synthesis. Nat Commun 6: 6801","journal-title":"Nat Commun"},{"key":"BFEMBR202154195_CR39","doi-asserted-by":"crossref","unstructured":"Liberman AC, Budzi\u00f1ski ML, Sokn C, Gobbini RP, Steininger A, Arzt E (2018) Regulatory and mechanistic actions of glucocorticoids on T and inflammatory cells. Front Endocrinol 9","DOI":"10.3389\/fendo.2018.00235"},{"key":"BFEMBR202154195_CR40","doi-asserted-by":"crossref","first-page":"21467","DOI":"10.1074\/jbc.272.34.21467","volume":"272","author":"J Liden","year":"1997","unstructured":"Liden J, Delaunay F, Rafter I, Gustafsson J\u2010\u00c5, Okret S (1997) A new function for the C\u2010terminal zinc finger of the glucocorticoid receptor: repression of RelA transactivation. J Biol Chem 272: 21467\u201321472","journal-title":"J Biol Chem"},{"key":"BFEMBR202154195_CR41","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.3109\/10428194.2013.866664","volume":"55","author":"Y Liu","year":"2014","unstructured":"Liu Y, Ge J, Li Q, Guo X, Gu L, Ma Z\u2010G, Li X\u2010H, Zhu Y\u2010P (2014) Low\u2010dose anisomycin sensitizes glucocorticoid\u2010resistant T\u2010acute lymphoblastic leukemia CEM\u2010C1 cells to dexamethasone\u2010induced apoptosis through activation of glucocorticoid receptor and p38\u2010MAPK\/JNK. Leuk Lymphoma 55: 2179\u20132188","journal-title":"Leuk Lymphoma"},{"key":"BFEMBR202154195_CR42","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.2147\/OTT.S201228","volume":"12","author":"L Liu","year":"2019","unstructured":"Liu L, Li Y, Pan B, Zhang T, Wei D, Zhu Y, Guo Y (2019) Nr5a2 promotes tumor growth and metastasis of gastric cancer AGS cells by Wnt\/beta\u2010catenin signaling. Onco Targets Ther 12: 2891\u20132902","journal-title":"Onco Targets Ther"},{"key":"BFEMBR202154195_CR43","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.bbamcr.2009.11.004","volume":"1803","author":"N Lopez\u2010Royuela","year":"2010","unstructured":"Lopez\u2010Royuela N, Balsas P, Galan\u2010Malo P, Anel A, Marzo I, Naval J (2010) Bim is the key mediator of glucocorticoid\u2010induced apoptosis and of its potentiation by rapamycin in human myeloma cells. Biochim Biophys Acta 1803: 311\u2013322","journal-title":"Biochim Biophys Acta"},{"key":"BFEMBR202154195_CR44","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.3389\/fimmu.2019.01693","volume":"10","author":"A Louw","year":"2019","unstructured":"Louw A (2019) GR dimerization and the impact of GR dimerization on GR protein stability and half\u2010life. Front Immunol 10: 1693","journal-title":"Front Immunol"},{"key":"BFEMBR202154195_CR45","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.01694","volume":"3","author":"JL Mamrosh","year":"2014","unstructured":"Mamrosh JL, Lee JM, Wagner M, Stambrook PJ, Whitby RJ, Sifers RN, Wu SP, Tsai MJ, Demayo FJ, Moore DD (2014) Nuclear receptor LRH\u20101\/NR5A2 is required and targetable for liver endoplasmic reticulum stress resolution. elife 3: e01694","journal-title":"elife"},{"key":"BFEMBR202154195_CR46","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","volume":"83","author":"DJ Mangelsdorf","year":"1995","unstructured":"Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P et\u2009al (1995) The nuclear receptor superfamily: the second decade. Cell 83: 835\u2013839","journal-title":"Cell"},{"key":"BFEMBR202154195_CR47","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1210\/me.2004-0333","volume":"19","author":"C Martens","year":"2005","unstructured":"Martens C, Bilodeau S, Maira M, Gauthier Y, Drouin J (2005) Protein\u2010protein interactions and transcriptional antagonism between the subfamily of NGFI\u2010B\/Nur77 orphan nuclear receptors and glucocorticoid receptor. Mol Endocrinol 19: 885\u2013897","journal-title":"Mol Endocrinol"},{"key":"BFEMBR202154195_CR48","doi-asserted-by":"crossref","first-page":"8330","DOI":"10.1128\/MCB.00852-07","volume":"27","author":"C Mataki","year":"2007","unstructured":"Mataki C, Magnier BC, Houten SM, Annicotte J\u2010S, Argmann C, Thomas C, Overmars H, Kulik W, Metzger D, Auwerx J et\u2009al (2007) Compromised intestinal lipid absorption in mice with a liver\u2010specific deficiency of liver receptor homolog 1. Mol Cell Biol 27: 8330\u20138339","journal-title":"Mol Cell Biol"},{"key":"BFEMBR202154195_CR49","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1210\/mend.12.1.0044","volume":"12","author":"LI McKay","year":"1998","unstructured":"McKay LI, Cidlowski JA (1998) Cross\u2010talk between nuclear factor\u2010kappa B and the steroid hormone receptors: mechanisms of mutual antagonism. Mol Endocrinol 12: 45\u201356","journal-title":"Mol Endocrinol"},{"key":"BFEMBR202154195_CR50","doi-asserted-by":"crossref","unstructured":"Merk VM, Phan TS, Brunner T (2021) Regulation of tissue immune responses by local glucocorticoids at epithelial barriers and their impact on interorgan crosstalk. Front Immunol 12","DOI":"10.3389\/fimmu.2021.672808"},{"key":"BFEMBR202154195_CR51","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/iub.2386","volume":"73","author":"S Michalek","year":"2020","unstructured":"Michalek S, Brunner T (2020) Nuclear\u2010mitochondrial crosstalk: on the role of the nuclear receptor liver receptor homolog\u20101 (NR5A2) in the regulation of mitochondrial metabolism, cell survival, and cancer. IUBMB Life 73: 592\u2013610","journal-title":"IUBMB Life"},{"key":"BFEMBR202154195_CR52","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1046\/j.1365-2141.2003.04217.x","volume":"120","author":"K Mihara","year":"2003","unstructured":"Mihara K, Imai C, Coustan\u2010Smith E, Dome JS, Dominici M, Vanin E, Campana D (2003) Development and functional characterization of human bone marrow mesenchymal cells immortalized by enforced expression of telomerase. Br J Haematol 120: 846\u2013849","journal-title":"Br J Haematol"},{"key":"BFEMBR202154195_CR53","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2105-11-30","volume":"11","author":"B Misselwitz","year":"2010","unstructured":"Misselwitz B, Strittmatter G, Periaswamy B, Schlumberger MC, Rout S, Horvath P, Kozak K, Hardt W\u2010D (2010) Enhanced CellClassifier: a multi\u2010class classification tool for microscopy images. BMC Bioinformatics 11: 30","journal-title":"BMC Bioinformatics"},{"key":"BFEMBR202154195_CR54","doi-asserted-by":"crossref","first-page":"5798","DOI":"10.1158\/0008-5472.CAN-16-0122","volume":"76","author":"B Murphy","year":"2016","unstructured":"Murphy B, Yin H, Maris JM, Kolb EA, Gorlick R, Reynolds CP, Kang MH, Keir ST, Kurmasheva RT, Dvorchik I et\u2009al (2016) Evaluation of alternative in\u2009vivo drug screening methodology: a single mouse analysis. Cancer Res 76: 5798\u20135809","journal-title":"Cancer Res"},{"key":"BFEMBR202154195_CR55","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1080\/15384047.2015.1045693","volume":"16","author":"C Nadolny","year":"2015","unstructured":"Nadolny C, Dong X (2015) Liver receptor homolog\u20101 (LRH\u20101): a potential therapeutic target for cancer. Cancer Biol Ther 16: 997\u20131004","journal-title":"Cancer Biol Ther"},{"key":"BFEMBR202154195_CR56","volume-title":"Endotext","author":"NC Nicolaides","year":"2000","unstructured":"Nicolaides NC, Pavlaki AN, Maria Alexandra MA, Chrousos GP (2000) Glucocorticoid therapy and adrenal suppression. In Endotext, KR Feingold, B Anawalt, A Boyce, G Chrousos, K Dungan, A Grossman, JM Hershman, G Kaltsas, C Kosh, P Kopp et\u2009al (eds). South Dartmouth, MA: MDText.com, Inc"},{"key":"BFEMBR202154195_CR57","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","volume":"139","author":"I Nicoletti","year":"1991","unstructured":"Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139: 271\u2013279","journal-title":"J Immunol Methods"},{"key":"BFEMBR202154195_CR58","doi-asserted-by":"crossref","first-page":"6350","DOI":"10.1073\/pnas.0501976102","volume":"102","author":"B Nyfeler","year":"2005","unstructured":"Nyfeler B, Michnick SW, Hauri HP (2005) Capturing protein interactions in the secretory pathway of living cells. Proc Natl Acad Sci U S A 102: 6350\u20136355","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFEMBR202154195_CR59","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/emboj\/17.2.384","volume":"17","author":"L O'Connor","year":"1998","unstructured":"O'Connor L, Strasser A, O'Reilly LA, Hausmann G, Adams JM, Cory S, Huang DC (1998) Bim: a novel member of the Bcl\u20102 family that promotes apoptosis. EMBO J 17: 384\u2013395","journal-title":"EMBO J"},{"key":"BFEMBR202154195_CR60","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3389\/fonc.2021.617937","volume":"11","author":"M Olivas\u2010Aguirre","year":"2021","unstructured":"Olivas\u2010Aguirre M, Torres\u2010L\u00f3pez L, Pottosin I, Dobrovinskaya O (2021) Overcoming glucocorticoid resistance in acute lymphoblastic leukemia: repurposed drugs can improve the protocol. Front Oncol 11: 647","journal-title":"Front Oncol"},{"key":"BFEMBR202154195_CR61","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1172\/JCI62368","volume":"122","author":"MH Oosterveer","year":"2012","unstructured":"Oosterveer MH, Mataki C, Yamamoto H, Harach T, Moullan N, van Dijk TH, Ayuso E, Bosch F, Postic C, Groen AK et\u2009al (2012) LRH\u20101\u2010dependent glucose sensing determines intermediary metabolism in liver. J Clin Invest 122: 2817\u20132826","journal-title":"J Clin Invest"},{"key":"BFEMBR202154195_CR62","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nsmb910","volume":"12","author":"EA Ortlund","year":"2005","unstructured":"Ortlund EA, Lee Y, Solomon IH, Hager JM, Safi R, Choi Y, Guan Z, Tripathy A, Raetz CR, McDonnell DP et\u2009al (2005) Modulation of human nuclear receptor LRH\u20101 activity by phospholipids and SHP. Nat Struct Mol Biol 12: 357\u2013363","journal-title":"Nat Struct Mol Biol"},{"key":"BFEMBR202154195_CR63","doi-asserted-by":"crossref","first-page":"83626","DOI":"10.18632\/oncotarget.18886","volume":"8","author":"JB Pang","year":"2017","unstructured":"Pang JB, Molania R, Chand A, Knower K, Takano EA, Byrne DJ, Mikeska T, Millar EKA, Lee CS, O'Toole SA et\u2009al (2017) LRH\u20101 expression patterns in breast cancer tissues are associated with tumour aggressiveness. Oncotarget 8: 83626\u201383636","journal-title":"Oncotarget"},{"key":"BFEMBR202154195_CR64","doi-asserted-by":"crossref","first-page":"21206","DOI":"10.1074\/jbc.M401523200","volume":"279","author":"JF Pare","year":"2004","unstructured":"Pare JF, Malenfant D, Courtemanche C, Jacob\u2010Wagner M, Roy S, Allard D, Belanger L (2004) The fetoprotein transcription factor (FTF) gene is essential to embryogenesis and cholesterol homeostasis and is regulated by a DR4 element. J Biol Chem 279: 21206\u201321216","journal-title":"J Biol Chem"},{"key":"BFEMBR202154195_CR65","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1950.02920160023005","volume":"144","author":"OH Pearson","year":"1950","unstructured":"Pearson OH, Eliel LP (1950) Use of pituitary adrenocorticotropic hormone (ACTH) and cortisone in lymphomas and leukemias. J Am Med Assoc 144: 1349\u20131353","journal-title":"J Am Med Assoc"},{"key":"BFEMBR202154195_CR66","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-3-319-45950-9_3","volume-title":"The hypothalamic\u2010pituitary\u2010adrenal axis in health and disease","author":"M Petrillo","year":"2017","unstructured":"Petrillo M, Bortner C, Cidlowski J (2017) Glucocorticoids: Inflammation and immunity. In The hypothalamic\u2010pituitary\u2010adrenal axis in health and disease, AB Geer (ed) pp 43\u201363. Cham: Springer International Publishing"},{"key":"BFEMBR202154195_CR67","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1002\/j.1460-2075.1987.tb02654.x","volume":"6","author":"D Picard","year":"1987","unstructured":"Picard D, Yamamoto KR (1987) Two signals mediate hormone\u2010dependent nuclear localization of the glucocorticoid receptor. EMBO J 6: 3333\u20133340","journal-title":"EMBO J"},{"key":"BFEMBR202154195_CR68","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.3390\/cancers11121852","volume":"11","author":"BA Porter","year":"2019","unstructured":"Porter BA, Ortiz MA, Bratslavsky G, Kotula L (2019) Structure and function of the nuclear receptor superfamily and current targeted therapies of prostate cancer. Cancer 11: 1852","journal-title":"Cancer"},{"key":"BFEMBR202154195_CR69","first-page":"1378","volume":"59","author":"J Ramdas","year":"1999","unstructured":"Ramdas J, Liu W, Harmon JM (1999) Glucocorticoid\u2010induced cell death requires autoinduction of glucocorticoid receptor expression in human leukemic T cells. Cancer Res 59: 1378\u20131385","journal-title":"Cancer Res"},{"key":"BFEMBR202154195_CR70","doi-asserted-by":"crossref","unstructured":"Richter\u2010Pecha\u0144ska P, Kunz JB, Bornhauser B, von Knebel DC, Rausch T, Erarslan\u2010Uysal B, Assenov Y, Frismantas V, Marovca B, Waszak SM et\u2009al (2018) PDX models recapitulate the genetic and epigenetic landscape of pediatric T\u2010cell leukemia. EMBO Mol Med 10","DOI":"10.15252\/emmm.201809443"},{"key":"BFEMBR202154195_CR71","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1038\/sj.cdd.4401413","volume":"11","author":"S Riml","year":"2004","unstructured":"Riml S, Schmidt S, Ausserlechner MJ, Geley S, Kofler R (2004) Glucocorticoid receptor heterozygosity combined with lack of receptor auto\u2010induction causes glucocorticoid resistance in Jurkat acute lymphoblastic leukemia cells. Cell Death Differ 11: S65\u2013S72","journal-title":"Cell Death Differ"},{"key":"BFEMBR202154195_CR72","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S1097-2765(03)00236-3","volume":"11","author":"EP Sablin","year":"2003","unstructured":"Sablin EP, Krylova IN, Fletterick RJ, Ingraham HA (2003) Structural basis for ligand\u2010independent activation of the orphan nuclear receptor LRH\u20101. Mol Cell 11: 1575\u20131585","journal-title":"Mol Cell"},{"key":"BFEMBR202154195_CR73","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana NE, Shalem O, Zhang F (2014) Improved vectors and genome\u2010wide libraries for CRISPR screening. Nat Methods 11: 783\u2013784","journal-title":"Nat Methods"},{"key":"BFEMBR202154195_CR74","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0008-6363(99)00384-3","volume":"45","author":"A Saraste","year":"2000","unstructured":"Saraste A, Pulkki K (2000) Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res 45: 528\u2013537","journal-title":"Cardiovasc Res"},{"key":"BFEMBR202154195_CR75","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1182\/blood-2010-11-320309","volume":"118","author":"M Schmitz","year":"2011","unstructured":"Schmitz M, Breithaupt P, Scheidegger N, Cario G, Bonapace L, Meissner B, Mirkowska P, Tchinda J, Niggli FK, Stanulla M et\u2009al (2011) Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartment. Blood 118: 1854\u20131864","journal-title":"Blood"},{"key":"BFEMBR202154195_CR76","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/embo-reports\/kvf238","volume":"3","author":"K Schoonjans","year":"2002","unstructured":"Schoonjans K, Annicotte JS, Huby T, Botrugno OA, Fayard E, Ueda Y, Chapman J, Auwerx J (2002) Liver receptor homolog 1 controls the expression of the scavenger receptor class B type I. EMBO Rep 3: 1181\u20131187","journal-title":"EMBO Rep"},{"key":"BFEMBR202154195_CR77","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/0092-8674(90)90397-W","volume":"62","author":"R Schule","year":"1990","unstructured":"Schule R, Rangarajan P, Kliewer S, Ransone LJ, Bolado J, Yang N, Verma IM, Evans RM (1990) Functional antagonism between oncoprotein c\u2010Jun and the glucocorticoid receptor. Cell 62: 1217\u20131226","journal-title":"Cell"},{"key":"BFEMBR202154195_CR78","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.173","volume":"8","author":"J Schwaderer","year":"2017","unstructured":"Schwaderer J, Gaiser A\u2010K, Phan TS, Delgado M, Brunner T (2017) Liver receptor homolog\u20101 (NR5a2) regulates CD95\/Fas ligand transcription and associated T\u2010cell effector functions. Cell Death Dis 8: e2745","journal-title":"Cell Death Dis"},{"key":"BFEMBR202154195_CR79","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41419-020-2348-9","volume":"11","author":"J Schwaderer","year":"2020","unstructured":"Schwaderer J, Phan TS, Glockner A, Delp J, Leist M, Brunner T, Delgado ME (2020) Pharmacological LRH\u20101\/Nr5a2 inhibition limits pro\u2010inflammatory cytokine production in macrophages and associated experimental hepatitis. Cell Death Dis 11: 154","journal-title":"Cell Death Dis"},{"key":"BFEMBR202154195_CR80","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav9732","volume":"5","author":"C Seitz","year":"2019","unstructured":"Seitz C, Huang J, Geiselhoringer AL, Galbani\u2010Bianchi P, Michalek S, Phan TS, Reinhold C, Dietrich L, Schmidt C, Corazza N et\u2009al (2019) The orphan nuclear receptor LRH\u20101\/NR5a2 critically regulates T cell functions. Sci Adv 5: eaav9732","journal-title":"Sci Adv"},{"key":"BFEMBR202154195_CR81","doi-asserted-by":"crossref","first-page":"23058","DOI":"10.18632\/oncotarget.5492","volume":"6","author":"RV Sionov","year":"2015","unstructured":"Sionov RV, Vlahopoulos SA, Granot Z (2015) Regulation of bim in health and disease. Oncotarget 6: 23058\u201323134","journal-title":"Oncotarget"},{"key":"BFEMBR202154195_CR82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0079-6123(10)82001-1","volume":"182","author":"LK Smith","year":"2010","unstructured":"Smith LK, Cidlowski JA (2010) Glucocorticoid\u2010induced apoptosis of healthy and malignant lymphocytes. Prog Brain Res 182: 1\u201330","journal-title":"Prog Brain Res"},{"key":"BFEMBR202154195_CR83","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ceb.2014.10.007","volume":"33","author":"S Stein","year":"2015","unstructured":"Stein S, Schoonjans K (2015) Molecular basis for the regulation of the nuclear receptor LRH\u20101. Curr Opin Cell Biol 33: 26\u201334","journal-title":"Curr Opin Cell Biol"},{"key":"BFEMBR202154195_CR84","doi-asserted-by":"crossref","first-page":"e577","DOI":"10.1038\/bcj.2017.53","volume":"7","author":"T Terwilliger","year":"2017","unstructured":"Terwilliger T, Abdul\u2010Hay M (2017) Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J 7: e577","journal-title":"Blood Cancer J"},{"key":"BFEMBR202154195_CR85","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.3389\/fimmu.2019.01545","volume":"10","author":"S Timmermans","year":"2019","unstructured":"Timmermans S, Souffriau J, Libert C (2019) A general introduction to glucocorticoid biology. Front Immunol 10: 1545","journal-title":"Front Immunol"},{"key":"BFEMBR202154195_CR86","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson \u00c5, Kampf C, Sj\u00f6stedt E, Asplund A et\u00a0al (2015) Proteomics. Tissue\u2010based map of the human proteome. Science 347: 1260419","journal-title":"Science"},{"key":"BFEMBR202154195_CR87","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/pro.3496","volume":"27","author":"ER Weikum","year":"2018","unstructured":"Weikum ER, Liu X, Ortlund EA (2018) The nuclear receptor superfamily: a structural perspective. Protein Sci 27: 1876\u20131892","journal-title":"Protein Sci"},{"key":"BFEMBR202154195_CR88","first-page":"2833","volume":"16","author":"C Wu","year":"2018","unstructured":"Wu C, Feng J, Li L, Wu Y, Xie H, Yin Y, Ye J, Li Z (2018) Liver receptor homologue 1, a novel prognostic marker in colon cancer patients. Oncol Lett 16: 2833\u20132838","journal-title":"Oncol Lett"},{"key":"BFEMBR202154195_CR90","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.2147\/CMAR.S162887","volume":"10","author":"L Xiao","year":"2018","unstructured":"Xiao L, Wang Y, Liang W, Liu L, Pan N, Deng H, Li L, Zou C, Chan FL, Zhou Y (2018) LRH\u20101 drives hepatocellular carcinoma partially through induction of c\u2010myc and cyclin E1, and suppression of p21. Cancer Manag Res 10: 2389\u20132400","journal-title":"Cancer Manag Res"},{"key":"BFEMBR202154195_CR91","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1101\/gad.277483.116","volume":"30","author":"P Xu","year":"2016","unstructured":"Xu P, Oosterveer MH, Stein S, Demagny H, Ryu D, Moullan N, Wang X, Can E, Zamboni N, Comment A et\u2009al (2016) LRH\u20101\u2010dependent programming of mitochondrial glutamine processing drives liver cancer. Genes Dev 30: 1255\u20131260","journal-title":"Genes Dev"},{"key":"BFEMBR202154195_CR92","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.csbj.2015.09.001","volume":"13","author":"B Yadav","year":"2015","unstructured":"Yadav B, Wennerberg K, Aittokallio T, Tang J (2015) Searching for Drug Synergy in Complex Dose\u2010Response Landscapes Using an Interaction Potency Model. Comput Struct Biotechnol J 13: 504\u2013513","journal-title":"Comput Struct Biotechnol J"}],"container-title":["The EMBO Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/embr.202154195.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/embr.202154195","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/embr.202154195\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/embr.202154195","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/embr.202154195.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:00:45Z","timestamp":1779112845000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/embr.202154195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":91,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9,5]]}},"alternative-id":["BFEMBR202154195"],"URL":"https:\/\/doi.org\/10.15252\/embr.202154195","relation":{},"ISSN":["1469-221X","1469-3178"],"issn-type":[{"value":"1469-221X","type":"print"},{"value":"1469-3178","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,8]]},"assertion":[{"value":"20 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}],"article-number":"EMBR202154195"}}